Trade Ideas March 23, 2026

Buy the Dip in Goldman Sachs: A Practical Mid-Term Trade Plan

Strong fundamentals, reasonable valuation, and a 20% selloff create a tactical long opportunity.

By Jordan Park GS
Buy the Dip in Goldman Sachs: A Practical Mid-Term Trade Plan
GS

Goldman Sachs (GS) has pulled back roughly 20% from recent highs, dragging the stock into a valuation that looks attractive relative to earnings and book value. We lay out a mid-term trade: entry at $835.00, stop at $795.00, target $960.00, and a 45-trading-day horizon. The trade leans on a favorable P/E (~15), healthy ROE (13%), and demonstrable technical oversold conditions, while flagging key risks including FCF weakness, trading revenue cyclicality, and macro recession risk.

Key Points

  • Buy Goldman Sachs at $835.00 for a mid-term rebound; stop $795.00, target $960.00.
  • Valuation is attractive: mid-teens P/E with ~13% ROE and sub-2x book value on several measures.
  • Technical setup favors mean reversion: RSI ~39, price near short-term EMAs and the 10-day SMA.
  • Primary risks: negative free cash flow, trading revenue cyclicality, macro recession, and leverage.

Hook & thesis

Goldman Sachs Group Inc. (GS) has been caught up in a broad financials selloff; the stock is down roughly 20% from recent highs and now trades at about $834.97. That pullback is the short-term pain that offers a disciplined entry for willing investors. Our view: buy a tactical position now with a defined stop and target. The company’s earnings power, measured returns, and reasonable price multiples give asymmetric upside into a mid-term recovery in the financial sector.

Why the market should care

Goldman is not a narrow trading house. It runs three material businesses: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. Those segments give GS exposure to advisory and underwriting fees, principal markets activity, recurring asset-management economics, and consumer-facing platform revenue. If markets stabilize and credit/volatility conditions normalize, the firm can re-lever its advantage in capital markets while recurring fees support margins.

Numbers that matter

Here are the concrete metrics underpinning the thesis:

  • Market capitalization: approximately $241.48 billion.
  • Price-to-earnings: roughly 14.8x - 15.9x depending on the snapshot used. Trailing earnings per share are about $54.93, which supports the current price at a mid-teens P/E.
  • Price-to-book: around 1.9x - 2.2x, implying the market is valuing the franchise at a modest premium to book.
  • Return on equity: ~13.04%, which is healthy for a diversified investment bank and suggests the business earns attractive returns on capital.
  • Enterprise multiples: EV/EBITDA ~22.3 and EV/Sales ~3.89 - elevated but consistent with a capital markets franchise where earnings can re-price quickly with revenue swings.
  • Balance sheet signals: debt-to-equity sits around 3.28 and short-interest days-to-cover has fallen to roughly 2.5 days, indicating limited structural short pressure.
  • Technical: the 10-day simple moving average is $808.97, RSI near 39 signals the stock is leaning toward oversold, and 9/21-day EMAs are $813/$839 respectively - price is sitting inside a short-term mean reversion zone.

Valuation framing

At a market cap near $241 billion and EPS of $54.93, Goldman trades in the mid-teens P/E band and sub-2x book on several measures. For a bank with a 13% ROE, that is not a stretched multiple relative to historical norms for leading investment banks. EV/EBITDA at 22x looks rich on the surface, but that number is distorted by cyclical earnings and the firm's sizable non-operating items. Put differently: if trading and principal revenues recover, multiples can compress even as absolute earnings rise. The 52-week range is wide - a low of $439.38 (04/07/2025) to a high of $984.70 (01/16/2026) - highlighting the stock’s cyclical amplitude and why disciplined entries matter.

Trade idea - actionable plan

Entry: Buy at $835.00. This sits essentially at the market and above the 9-day EMA, letting you participate if market breadth recovers.

Stop: $795.00. A breach below $795 would be a clear technical failure under the 10-day SMA and recent short-term support, limiting downside.

Target: $960.00. This target is below the 52-week high ($984.70 on 01/16/2026) and represents a sensible mid-term re-rating if trading revenues and advisory activity normalize.

Horizon: mid term (45 trading days). The logic: capital markets and trading revenue swings can reverse meaningfully over several weeks as volatility, underwriting calendars, and macro headlines shift. This 45-trading-day window gives time for a relief rally while keeping the trade disciplined.

Position sizing and risk posture

Treat this as a tactical long with a medium risk allocation inside a diversified portfolio. The stop at $795 keeps downside defined; the risk/reward from entry to target is roughly 15% upside against about 4.8% downside to the stop. Adjust position size to where that downside represents an acceptable portfolio-level loss.

Catalysts to watch (2-5)

  • Sector sentiment improvement - a rebound in capital markets activity or a pause in the broader financials selloff could trigger re-rating.
  • Earnings or revenue misses/beat from peers and from Goldman itself - next corporate reporting and commentary can re-shape guidance and trading outlook.
  • Dividend and buyback signals - the company has an upcoming payable date on 03/30/2026 and an ex-dividend date of 03/02/2026; capital return language or increases would underpin valuation.
  • Macro stabilization - easing geopolitical risk and lower oil/energy prices would reduce recession probability and revive fee and trading pools.

Risks and counterarguments

We include at least four risks and a counterargument to the bullish thesis:

  • Free cash flow weakness - the company shows a materially negative free cash flow figure (~-$46.4 billion). Persistent negative FCF or lumpy cash flow dynamics constrain buybacks and capital returns and can pressure the stock if they persist.
  • Trading revenue cyclicality - a large share of Goldman’s earnings can come from market-dependent trading and principal activities. Prolonged market quiet or another volatility shock that reduces client activity would hit near-term earnings hard.
  • Macro / recession risk - an economic slowdown or recession would reduce underwriting, M&A, and advisory fees, compressing revenue and multiplying downside pressure across banks.
  • Leverage & balance-sheet dynamics - debt-to-equity at ~3.28 is not trivial. If credit conditions deteriorate, provisioning and funding costs could rise.
  • Counterargument: the negative free cash flow and high EV/EBITDA suggest the valuation already prices in meaningful execution risk; if those structural issues continue or worsen, the stock can trade well below current levels despite an apparently low P/E. In short, cheap can be cheap for a reason.

What would change our view

We would become more constructive if the firm reports a return to positive and growing free cash flow, or if management signals sustainable lift in recurring revenue streams (Asset & Wealth Management and Platform Solutions) offsetting trading cyclicality. Conversely, repeated negative guidance, missed earnings, or an explicit cut to capital returns would make us step back and potentially flip neutral or bearish.

Conclusion

Goldman Sachs is a high-quality franchise trading at a multi-week discounted level after a sharp pullback. The valuation is supportable given a ~13% ROE and mid-teens P/E, and the technicals suggest the stock is in an area where short-term mean reversion is plausible. The trade is not without risk - negative free cash flow, cyclical revenue, and macro threats are real. For disciplined traders and investors willing to accept a defined downside, a buy at $835.00 with a $795.00 stop and a $960.00 target over the next 45 trading days is our preferred mid-term tactical play.

Quick reference table

Metric Value
Current price $834.97
Market cap $241.48B
Trailing EPS $54.93
P/E ~15x
Price-to-book ~1.9x - 2.2x
ROE ~13%
EV/EBITDA ~22.3x

Notable recent market context: analysts called both Wells Fargo and Goldman Sachs oversold on 03/13/2026 as the sector reacted to geopolitical and macro headlines. That same day the idea of using pullbacks as tactical entries was highlighted across the sector.

Trade plan recap: Buy $835.00, stop $795.00, target $960.00. Horizon: mid term (45 trading days). Risk level: medium.

If you follow this trade, size it so that a stop at $795.00 represents an acceptable portfolio loss. Monitor market breadth, trading-volume trends, and quarterly commentary closely; those will drive the speed and size of any rally back toward our $960 objective.

Risks

  • Negative free cash flow (~-$46.4B) could limit capital returns and create investor concern if persistent.
  • Earnings sensitivity to capital markets activity means a prolonged market downturn would materially hit revenue.
  • Higher funding costs or credit stress could increase provisions and compress margins given leverage (debt-to-equity ~3.28).
  • Macro recession risk or sustained geopolitical volatility would ratchet down advisory and underwriting fees, pushing multiples lower.

More from Trade Ideas

Yara: Positioned to Profit from a Urea Price Shock Apr 5, 2026 Occidental (OXY): Why Buffett’s Bet Still Has Room to Run Apr 5, 2026 XPEL Setup: Durable Margins, Activist Backing, and a Clear Path to Re-rate Apr 5, 2026 AngioDynamics: Growth Is Real, but Leadership Noise Makes This a Tactical Buy Apr 5, 2026 Oracle: OCI Execution and Multicloud Momentum Make the Case to Buy Apr 5, 2026